Seven Fleet Capital Management’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.08M Buy
4,421,739
+73,913
+2% +$151K 1.19% 17
2026
Q2
$10.7M Buy
4,347,826
+1,400,000
+47% +$3.2M 1.76% 11
2026
Q1
$6.66M Buy
+2,947,826
New +$6.2M 2.09% 7

Other funds holding IPSC

Seven Fleet Capital Management's IPSC Position: Q3 2026 in Review

Seven Fleet Capital Management increased its Century Therapeutics (IPSC) stake by 1.7% in Q3 2026, buying an estimated $151K and bringing the position to 4,421,739 shares worth $6.08M. The position accounts for 1.19% of the portfolio, ranked #17.

Seven Fleet Capital Management first reported a position in IPSC in Q1 2026 and has held it in 3 quarters since. The position peaked at $10.7M in Q2 2026. 102 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

  • Seven Fleet Capital Management held 4,421,739 shares of Century Therapeutics worth $6.08M as of Q3 2026.
  • Seven Fleet Capital Management bought 73,913 Century Therapeutics shares in Q3 2026, an estimated $151K.
  • Century Therapeutics made up 1.19% of Seven Fleet Capital Management's portfolio in Q3 2026, its #17 holding.
  • Seven Fleet Capital Management first reported a position in Century Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Seven Fleet Capital Management's Century Therapeutics position peaked at $10.7M in Q2 2026.
  • 102 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on Seven Fleet Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.